Status:
ENROLLING_BY_INVITATION
Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine Treatment
Lead Sponsor:
Yale University
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigators aim to examine the role of audiovisual inputs during treatment with ketamine/esketamine in affecting tolerability and effectiveness of treatment of depressive episodes, by providing pati...
Eligibility Criteria
Inclusion
- Participants must be at least 18 years old
- Patients must have completed the acute series of treatment and weekly optimization phases of ketamine/esketamine treatment, and currently receiving continuation/maintenance treatment Written consent for the study procedures
- Ability and willingness, in the investigator's judgement, to comply with the study procedure and study requirements.
Exclusion
- Hearing or visual impairment to the degree that would interfere with ability to see or hear VR content.
- Difficulty in understanding spoken or written English
- Unable to provide informed consent
- Dementia or other cognitive disorder or intellectual disability that would impair the subject's ability to understand the study procedure (per investigator judgment)
- Any other medical or psychiatric comorbidity that the investigator judges would put the participant at additional undue risk due to study participation or would impair subject's ability to participate in the study.
- Was previously enrolled/randomized into the study
Key Trial Info
Start Date :
July 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06139016
Start Date
July 11 2024
End Date
December 1 2025
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Psychiatry Hospital Interventional Psychiatry Services (IPS) unit
New Haven, Connecticut, United States, 06520